New drugs in cystic fibrosis: what has changed in the last decade?

Cystic fibrosis (CF), a life-limiting chronic disease caused by mutations in the cystic fibrosis transmembrane regulator (CFTR) gene, affects more than 90,000 people worldwide. Until recently, the only available treatments were directed to symptom control, but they failed to change the course of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Roda, Juliana, Pinto-Silva, Catarina, Silva, Iris A.I., Maia, Carla, Almeida, Susana, Ferreira, Ricardo, Oliveira, Guiomar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128052/
https://www.ncbi.nlm.nih.gov/pubmed/35620188
http://dx.doi.org/10.1177/20406223221098136

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128052/
https://www.ncbi.nlm.nih.gov/pubmed/35620188
http://dx.doi.org/10.1177/20406223221098136

Ejemplares similares